Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Market Insights | Asia Pacific | 2023

The COVID-19 pandemic severely impacted the Asia Pacific GI endoscopy device market, as it forced healthcare providers to focus on life-threatening procedures, deferring elective and non-emergent procedures. Owing to the elective nature of many of the GI endoscopy procedures, market recovery has been hindered by multiple regional and global obstacles. Nonetheless, following short-term disruption due to the global pandemic, the Asia Pacific GI endoscopy device market will grow throughout the remainder of the forecast period, primarily driven by the growth of underpenetrated endoscopy procedure volumes.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in Asia Pacific from 2019 through 2031.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…